We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Will a Change of Diet Prevent Cancer?

By LabMedica International staff writers
Posted on 30 Jun 2011
Print article
Cancer researchers have found that a diet low in carbohydrates and high in protein reduced the risk of developing some types of cancer in a mouse model.

Investigators at the University of British Columbia (Vancouver, Canada) postulated that fast growing cancer cells should require significantly more glucose to grow and thrive than normal cells. Furthermore, they reasoned that restricting glucose intake might slow or prevent tumor growth.

To examine this concept they implanted human tumor cells into various strains of mice, some of which were also growing mouse tumors. The mice were separated into two groups. One group was fed a typical Western diet, containing about 55% carbohydrate, 23% protein, and 22% fat. The second group received a highly modified diet (low CHO diet) that contained 15% carbohydrate, 58% protein, and 26% fat.

Results published in the June 14, 2011, online edition of the journal Cancer Research revealed that both mouse and human tumors grew more slowly in the mice that received the low CHO diet. While there was no significant weight difference between the tumor-bearing mice on the low CHO or Western diets, the low CHO-fed mice exhibited lower blood glucose, insulin, and lactate.

Combining a low CHO diet with chemotherapy increased the effect of the mTOR inhibitor CCI-779 and especially that of the potent anti-inflammatory COX-2 inhibitor Celebrex. In a genetically engineered mouse model of HER-2/neu–induced mammary cancer, tumor penetrance in mice on a Western diet was nearly 50% by the age of one year whereas no tumors were detected in mice on the low CHO diet.

Only one mouse on the Western diet achieved a normal life span, due to cancer-associated deaths, while more than 50% of the mice on the low CHO diet reached or exceeded the normal life span. "This shows that something as simple as a change in diet can have an impact on cancer risk," said senior author Dr. Gerald Krystal, professor of pathology and laboratory medicine at the University of British Columbia.

Related Links:

University of British Columbia



New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Automated Blood Typing System
IH-500 NEXT
New
Flow Cytometer
BF – 710
New
CVD Risk Test
GammaCoeur CVD Risk ELISA Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.